文献
J-GLOBAL ID:201802216671262108
整理番号:18A1995980
民族性に基づく抗高血圧薬に対する異なる反応を評価する無作為化対照クロスオーバー試験:最適高血圧療法の比較 高血圧プログラムにおける祖先情報マーカーの一部 AIM-HY INFORM試験【JST・京大機械翻訳】
A randomized controlled crossover trial evaluating differential responses to antihypertensive drugs (used as mono- or dual therapy) on the basis of ethnicity: The comparIsoN oF Optimal Hypertension RegiMens; part of the Ancestry Informative Markers in HYpertension program-AIM-HY INFORM trial
著者 (23件):
Mukhtar Omar
(Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, United Kingdom)
,
Cheriyan Joseph
(Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, and Cambridge, and Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom)
,
Cockcroft John R.
(Department of Cardiology, Columbia University Medical Center, New York)
,
Collier David
(William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom)
,
Coulson James M.
(School of Medicine, Cardiff University, Heath Park Campus, Cardiff, United Kingdom)
,
Dasgupta Indranil
(Department of Renal Medicine, Heartlands Hospital, Birmingham, United Kingdom)
,
Faconti Luca
(Department of Clinical Pharmacology, King’s College London, British Heart Foundation Centre, London, United Kingdom)
,
Glover Mark
(Division of Therapeutics and Molecular Medicine, University of Nottingham, and NIHR Nottingham Biomedical Research Centre, Nottingham, United Kingdom)
,
Heagerty Anthony M.
(Division of Cardiovascular Sciences, University of Manchester, Manchester, United Kingdom)
,
Khong Teck K.
(Blood Pressure Unit, Cardiology Clinical Academic Group, St George’s University of London, Cranmer Terrace, London, United Kingdom)
,
Lip Gregory Y.H.
(Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom)
,
Mander Adrian P.
(Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom)
,
Marchong Mellone N.
(Office for Translational Research, Cambridge University Health Partners and University of Cambridge, Cambridge, United Kingdom)
,
Martin Una
(Institute of Clinical Sciences, University of Birmingham, Birmingham, United Kingdom)
,
McDonnell Barry J.
(Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom)
,
McEniery Carmel M.
(Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, Cambridge, United Kingdom)
,
Padmanabhan Sandosh
(Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom)
,
Saxena Manish
(William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom)
,
Sever Peter J.
(Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom)
,
Shiel Julian I.
(William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, London, United Kingdom)
,
Wych Julie
(Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom)
,
Chowienczyk Phil J.
(Department of Clinical Pharmacology, King’s College London, British Heart Foundation Centre, London, United Kingdom)
,
Wilkinson Ian B.
(Experimental Medicine & Immunotherapeutics Division, Department of Medicine, University of Cambridge, and Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom)
資料名:
American Heart Journal
(American Heart Journal)
巻:
204
ページ:
102-108
発行年:
2018年
JST資料番号:
A0904B
ISSN:
0002-8703
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)